您当前的位置:
首页 >
文章列表页 >
Zuoguiwan Treats Cyclophosphamide-induced Premature Ovarian Failure by Regulating SLC7A11/GPX4 Pathway to Inhibit Ferroptosis
更新时间:2024-07-31
    • Zuoguiwan Treats Cyclophosphamide-induced Premature Ovarian Failure by Regulating SLC7A11/GPX4 Pathway to Inhibit Ferroptosis

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 17, Pages: 60-66(2024)
    • DOI:10.13422/j.cnki.syfjx.20240903    

      CLC: R2-0;R22;R285.5;R289;R33
    • Received:11 April 2024

      Published Online:04 July 2024

      Published:05 September 2024

    移动端阅览

  • ZHAO Min,ZHANG Jinrong,HUA Jianghuan,et al.Zuoguiwan Treats Cyclophosphamide-induced Premature Ovarian Failure by Regulating SLC7A11/GPX4 Pathway to Inhibit Ferroptosis[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(17):60-66. DOI: 10.13422/j.cnki.syfjx.20240903.

  •  
  •  

0

Views

38

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Chinese and Western Medicine Treatment of Gastric Cancer via Ferroptosis: A Review
Application of Ferroptosis Regulation in Chronic Atrophic Gastritis Based on Spleen Deficiency and Turbid Toxin
Nano-traditional Chinese Medicine-Induced Cuproptosis and Ferroptosis in Tumor Resistance: A Review
Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure
Regulation of Ferroptosis by Traditional Chinese Medicine for Colorectal Cancer Intervention: A Review

Related Author

MA Yibin
LI Xiaojing
LIU Qiuhua
WANG Jie
GUO Yuxi
CAI Yanru
YANG Qian
GUO Yuxi

Related Institution

Graduate School, Hebei University of Chinese Medicine
Hebei Provincial Hospital of Traditional Chinese Medicine
Hebei Key Laboratory of Turbidity Toxin Syndrome
Hebei Hospital of Chinese Medicine
Hebei University of Chinese Medicine
0